Two experiments (EXPs) were conducted to evaluate models of immune system stimulation (ISS) that can be used in nutrient metabolism studies in growing pigs. In EXP I, the pig's immune response to three non-pathogenic immunogens was evaluated, whereas in EXP II the pig's more general response to one of the immunogens was contrasted with observations on non-ISS pigs. In EXP I, nine growing barrows were fitted with a jugular catheter, and after recovery assigned to one of three treatments. Three immunogens were tested during a 10-day ISS period: (i) repeated injection of increasing amounts of Escherichia coli lipopolysaccharide (LPS); (ii) repeated subcutaneous injection of turpentine (TURP); and (iii) feeding grains naturally contaminated with mycotoxins (MYCO). In EXP II, 36 growing barrows were injected repeatedly with either saline (n 5 12) or increasing amounts of LPS (n 5 24) for 7 days (initial dose 60 mg/kg body weight). Treating pigs with TURP and LPS reduced feed intake (P , 0.02), whereas feed intake was not reduced in pigs on MYCO. Average daily gain (ADG; kg/day) of pigs on LPS (0.50) was higher than that of pigs on TURP (0.19), but lower than that of pigs on MYCO (0.61; P , 0.01). Body temperature was elevated in pigs on LPS and TURP, by 0.88C and 0.78C, respectively, relative to pre-ISS challenge values (39.38C; P , 0.02), but remained unchanged in pigs on MYCO. Plasma concentrations of interleukin-1b were increased in pigs treated with LPS and TURP (56% and 55%, respectively, relative to 22.3 pg/ml for pre-ISS; P , 0.01), but not in MYCO-treated pigs. Plasma cortisol concentrations remained unchanged for pigs on MYCO and TURP, but were reduced in LPS-treated pigs (30% relative to 29.8 ng/ml for pre-ISS; P , 0.05). Red blood cell glutathione concentrations were lower in TURP-treated pigs (13% relative to 1.38 mM for pre-ISS; P , 0.05), but were unaffected in pigs on LPS and MYCO. In EXP I, TURP caused severe responses including skin ulceration and substantial reductions in feed intake and ADG, whereas MYCO did not induce effective ISS. In EXP II, ISS increased relative organ weights, eye temperature, white blood cell count and plasma acute-phase proteins (P , 0.05), confirming that repeated injection with increasing amounts of LPS induced chronic and relatively mild ISS. Repeated injection with increasing amounts of LPS is a suitable model for studying nutrient metabolism and evaluating the efficacy of nutritional intervention during chronic ISS in growing pigs.
Introduction
For studying the impact of immune system stimulation (ISS) on nutrient metabolism and productivity of pigs, a model is needed that represents chronic ISS, is equivalent to subclinical or moderate clinical disease and can be used to evaluate the impact of potential (nutritional) interventions to alleviate the impact of ISS on animals. Various animal models of disease have been described in literature; however, most of them induce clinical disease symptoms, severe body weight (BW) loss and only allow short-term observations (Fink and Heard, 1990) . For instance, models in which animals are exposed to live pathogens are generally associated with high rates of mortality, extreme BW loss and anorexia, or variable responses (Wichterman et al., 1980; Fink and Heard, 1990) .
-E-mail: cdelange@uoguelph.ca Contrary to using live pathogens, dosages of non-pathogenic immunogens such as Escherichia coli lipopolysaccharide (LPS), inflammatory turpentine (TURP) or mycotoxins (MYCO) are easily controlled and can induce reproducible responses (Fink and Heard, 1990; Deitch, 1998) . In addition, limited biosecurity is needed when they are administered to animals. Administration of large single doses of these immunogens can cause severe responses, including high mortality and organ failure (Fink and Heard, 1990) . Reducing the dose of these antigens improves survival rates; however, animal recovery often occurs within 48 h after the challenge (Deitch, 1998) . Prolonged repeated administration (Van Heugten et al., 1996) or continued infusion (Fish and Spitzer, 1984) of LPS leads to endotoxin tolerance (Ash and Griffin, 1989; Deitch, 1998) .
The first objective of this study was to directly compare the impact of various non-pathogenic immunogens (LPS, TURP and MYCO) on indicators of ISS in growing pigs. The second objective was to contrast general measures of immune function in LPS-challenged pigs with unchallenged pigs. The overall aim was to establish a humane, chronic ISS model that represents subclinical or mild clinical disease and that can be used to study nutrient metabolism during ISS in growing pigs.
Material and methods
In our study, two experiments (EXPs) were conducted. In EXP I, pigs were exposed to three different non-pathogenic immunogens: LPS, TURP and MYCO. In EXP II, the ISS response of pigs treated with LPS was compared with that of unchallenged pigs. The experimental procedures were reviewed and approved by the University of Guelph, Animal Care Committee. Experimental design, diets and feeding In EXP I, nine Yorkshire barrows with initial BW of 24.7 6 0.40 kg were obtained from the University of Guelph, Arkell Swine Research Center (Arkell, ON, Canada) and housed individually in metabolism crates (Nyachoti et al., 1998) . After 7 days of adaptation to the environment, pigs were surgically fitted with a jugular catheter (Micro-Renathane, 1.6 mm i.d., 2.41 mm o.d.; Brain Tree Scientific Inc., Braintree, MA, USA) for serial blood sample collection (de Lange et al., 1989) , and allowed to recover for 10 days before the start of ISS. Three types of non-pathogenic immunogen were tested during a 10-day ISS period: (i) repeated injection of increasing amounts of E. coli LPS (serotype 055:B5, Sigma-aldrich Canada Ltd, Oakville, ON, Canada; cat. no. L2880); (ii) repeated injection of inflammatory TURP; and (iii) feeding grains naturally contaminated with MYCO. Pigs on LPS were injected intramuscularly every 48 h (total of five injections) with increasing amounts of LPS reconstituted in saline. The initial dosage of 60 mg/kg of BW was increased by 12% at each subsequent injection to reduce endotoxin tolerance. The initial dose of LPS was established on the basis of a pilot study in our laboratory in which plasma levels of interleukin-1b (IL-1b) were monitored for 48 h in four pigs. Pigs on TURP were injected subcutaneously (1.0 ml/kg of BW) every 72 h (total of three injections) according to Jahoor et al. (1995) and at different sites along the pig's back and the hindquarters. Pigs on LPS and TURP received the injections at ,1000 h and ,2 h after feeding. Pigs on MYCO were given a diet containing 5% naturally contaminated wheat. The diet contained a mixture of (mg/kg diet) deoxynivalenol (5.8), fusaric acid (49.3), zearalenone (0.5) and 15-acetyldeoxynivalenol (0.3), as described previously by Swamy et al. (2003) . Pigs were randomly assigned to the three treatments. All the pigs received conventional soybean meal and corn-based pig starter diets, formulated to contain 14.5 MJ/kg digestible energy, 9.6 g/kg standardized ileal digestible lysine and sufficient levels of essential nutrients according to National Research Council (NRC; 1998). The MYCO diet also contained 5% MYCO-contaminated wheat. The daily feed allowance was 1.2 kg, supplied in two equal meals at 0800 and 1600 h; feed refusals were removed and weighed just before feeding.
Detailed procedures for EXP II were described previously when the impact of ISS on aspects of nutrient utilization was reported (Rakhshandeh et al. 2010) . Briefly, 36 barrows (initial BW 21.5 6 3.5 kg) were housed individually in metabolic crates, and feed-restricted. After 9 days of adaptation to environmental conditions and dietary treatments, pigs were injected intramuscularly every 48 h with either increasing amounts of LPS (n 5 24) or sterile saline (n 5 12) for 7 days, as described for EXP I.
Observations, sample processing, chemical and statistical analyses In both the EXP, daily feed intake was monitored 3 days before and during ISS. BW was measured at the start (day 0) and end (day 10 or 7) of ISS and was used to calculate average daily gain (ADG) during ISS. In EXP I, blood samples were collected on a daily basis (,1400 h) in heparinized tubes and placed on ice until they were processed further. Rectal temperature was measured on a daily basis, immediately after blood sample collection. In EXP II, eye temperature was monitored using the infrared imaging technique as described previously by Montanholi et al. (2008) , and blood samples were collected using retro-orbital bleeding at day 7. Pigs were then immediately euthanized, a ventral abdominal incision was made, spleen and liver were removed, rinsed with physiological saline, blotted dry and weighed.
Blood plasma was obtained by centrifugation at 2000 3 g for 20 min at 48C. Plasma cortisol levels were determined using a competitive binding radioimmunoassay kit (GammaCoat [ 125 I] Cortisol, DiaSorin Inc., Stillwater, MN, USA; cat. no. CA-1529) according to the manufacturer's protocol with minor modifications. The amount of sample was increased threefold and incubation time was increased (from 45 min at 378C to overnight at room temperature) to increase the sensitivity of the assay (Marchant-Forde et al., 2003) . Plasma IL-1b levels were measured using the Quantikine porcine IL-1b immunoassay kit (R&D system Inc., Minneapolis, MN, USA; cat. no. PLB00). In order to quantify red blood cell (RBC) glutathione (GSH) concentrations (Jahoor et al., 1995) , 2 ml of heparinized blood was centrifuged at 1500 3 g for 10 min at 48C, plasma was removed and 0.5 ml of packed RBC were freeze-thawed several times in liquid nitrogen to lyse the cells. Lysed cells were then de-proteinized using meta-phosphoric acid at a final concentration of 5%. GSH concentrations were quantified in the supernatant using Tietze's enzymatic recycling method (GSH Assay Kit, WPI Inc., Sarasota, FL, USA; cat. no. 062404).
Blood levels of acute-phase proteins and complete blood count (CBC) were determined in the Animal Health Laboratory at the University of Guelph. Serum albumin (Doumas et al., 1971) and haptoglobin (Makimura and Suzuki. 1982) were analyzed using Roche Cobas c501 biochemistry analyzer (Roche Diagnostics, Indianapolis, IN, USA). Plasma fibrinogen was quantified using a KC4 Delta semi-automatic coagulation analyzer (Trinity Biotech, Wickland, Ireland) and a TirinitClot kit (TriniCLOT TM Fibrinogen, Trinity Biotech; cat. no. T1301). CBC was performed using ADIVA 120 Hematology System (Siemens Healthcare Diagnostics Inc., IL, USA).
Daily measurements, such as feed intake, body temperature (BT) and plasma levels of cortisol, IL-1b and GSH data were analyzed statistically as repeated measurements, on the basis of a complete randomized design (MIXED procedure in SAS, version 9.1, SAS institute Inc., Cary, NC, USA) with treatment, time (day) and the treatment by time interaction as fixed effects, and pig within treatment as random effect. In EXP I, the results obtained for each treatment during ISS (n 5 3) were compared with those obtained before ISS (n 5 9). Owing to the sequential nature of the observations on individual animals, a compound symmetry structure was determined to be the most appropriate fit. In EXP I, BW and BW gain data were analyzed using a complete randomized design (MIXED procedure in SAS) with treatment as fixed effect and pig within treatment as random effect. For EXP II, the same statistical analyses were performed, using a randomized complete block design with treatment and block as fixed effects and pig within treatments as random effect. The Tukey-Kramer test was used to compare treatment effects when the interaction between treatments and time was found to be significant. Differences were considered to be significant at P , 0.05. A tendency toward a significant difference between treatment means was also considered at P < 0.10.
Results
In EXP I, no differences between the treatment groups were observed for BW, BT, levels of plasma IL-1b and cortisol, RBC GSH and feed intake before ISS (P . 0.05). There were no mortalities in any of the treatment groups. In general, TURP induced severe local inflammation including skin ulcers on the back.
Relative to pre-ISS values, BT and plasma IL-1b concentrations were increased in pigs treated with LPS and TURP (P , 0.02), but not in MYCO-treated pigs (P . 0.10; Table 1), and remained elevated over the duration of study (Figure 1 ). Plasma cortisol concentrations remained unchanged for MYCO-and TURP-treated pigs, but were reduced for LPStreated pigs (Table 1 ; P , 0.01). RBC GSH concentrations were reduced in TURP-treated pigs, but were unchanged in LPS-and MYCO-treated pigs (P , 0.05). No interactive effect of treatments and time on plasma RBC GSH concentrations was observed (Table 1 ; P . 0.10).
In EXP II, treatment of pigs with LPS increased relative to the weight of spleen and liver (P , 0.01), eye temperature (P , 0.01), plasma fibrinogen (P , 0.04), serum haptoglobin (P , 0.01) and white blood cell count (P , 0.01; Table 2 ). No effects of ISS were observed on final BW, ADG, serum albumin, RBC count, hemoglobin and hematocrit (P . 0.10; Table 2 ). Experiment I: nine barrows were fed 1.2 kg/day of a soybean meal and corn-based conventional pig starter diet before and during a 10-day period of immune system stimulation (ISS); ISS was induced during a 10-day period using three non-pathogenic immunogens (Treat): Escherichia coli LPS, MYCO and inflammatory TURP. Data are least square means 6 s.e. Pre-ISS (day 0) measurements were not different between the treatment groups (P . 0.10).
3 Initial (day 0) and final (day 10) BW, BW gain and feed conversion ratio (feed : gain) during the 10-day period of ISS.
4
Average daily feed intake, BT, as well as plasma levels of IL-1b, cortisol and RBC GSH, based on daily observations.
Discussion
The main aim of this study was to establish a humane and chronic model of ISS that represents a subclinical or mild clinical disease and that allows for the evaluation of the impact of ISS on various aspects of nutrient metabolism. In EXP I, lack of statistical difference for all measured responses between treatment groups before ISS indicated that the pigs on the various treatments were at similar physiological states at the start of the study. In EXP II, it was shown that repeated injection of control animals with saline did not affect the reported measures of immune function, which is consistent with previous observations on growing pigs (Jahoor et al., 1995 and 1999) . It was thus concluded that treatment effects observed in EXP I can be attributed to the immunogens per se.
Relationships between growth performance and disease are mediated by proinflammatory cytokines (IL-1b, IL-6 and tumor necrosis factor-a (TNF-a)), which are synthesized and released mainly by mononuclear myeloid cells of the innate immune system upon exposure to pathogens (Buchanan and Johnson, 2007) . These cytokines shift the partitioning of nutrients from growth and reproduction toward supporting the immune system (Johnson, 1998; Buchanan and Johnson, 2007) . They also orchestrate central nervous system-specific response including fever, sleep, reductions in activity and feed intake, and activation of hypothalamic-pituitary-adrenal (HPA) axis (Johnson, 1998; Karrow, 2006) . Among these cytokines, IL-1b is involved in all aspects of the immune response including fever and anorexia. IL-1b can exert its anorectic effect by suppressed feeding behavior, decreased gastric emptying and motility (Johnson, 1998) , and increased circulating levels of glucagon, insulin and leptin (Meier and Gressner, 2004) . In this study, we observed a persistent increase in plasma concentration of IL-1b in pigs on LPS and TURP, which was consistent with the observed reductions in feed intake, increased BT and compromised growth performance. BW gain was reduced more severely in pigs on TURP than on LPS, even though plasma levels of IL-1b were similar for pigs on TURP and LPS. The latter indicates that plasma levels of IL-1b explain only partly the observed treatment effects on pig growth performance. Lower feed intake and performance of pigs on TURP relative to LPStreated pigs can also be attributed partly to higher plasma cortisol levels in these animals (Jahoor et al.,1999; Buchanan and Johnson, 2007) . Moreover, pain-associated behavior due to skin ulceration may also contribute to decreased feed intake and growth performance of TURP-treated pigs (Zimmermann, 2001 ). In this study, feeding naturally occurring MYCO did not increase the plasma levels of IL-1b, and therefore did not induce fever or provoke substantial reductions in feed intake or growth performance. MYCO have a suppressive effect on the immune system in general and on the activity of mononuclear myeloid cells in particular (Kidd et al., 1995; Oswald et al., 2005) . Changes in brain concentration of neurotransmitters seem to be, to a large extent, responsible for reduced feed intake in pigs fed MYCO (Swamy et al., 2002) . This indicates that the impact of MYCO on feed intake is not mediated by proinflammatory cytokines. It can also be speculated that, in this study, feed intake was restricted too severely to identify the impact of MYCO on feed intake. In a previous study by Swamy et al. (2002) , average daily feed intake (ADFI) of pigs (BW ,19.0 kg) receiving a very similar MYCO-contaminated diet was reported to be 1.45 kg/day, which was 20% higher than the feed allowance in this study. This, to a large extent, explains the lack of effect of MYCO on ADFI in our study. Acute disease provokes high plasma levels of the stress hormone cortisol, which appears to be induced by proinflammatory cytokines and particularly IL-1b (Webel et al., 1997) . However, during prolonged ISS (e.g. chronic disease) plasma cortisol levels are reduced, apparently to increase the animal's chance of survival (Heim et al., 2000; Fries et al., 2005) . In this study, we observed numerical or significant reductions in plasma cortisol levels in TURP-and LPS-treated pigs. Three potential mechanisms for adjustments to the HPA axis, which result in reduced plasma cortisol levels, have been suggested: (i) reduced expression of specific receptors on different levels of axis (e.g. glucocorticoid receptors); (ii) decreased synthesis or depletion of compounds such as corticotrophin-releasing hormone (CRH); adrenocorticotropic hormone and cortisol; or (iii) enhanced negative feedback sensitivity to glucocorticoids (Hellhammer and Wade, 1993) . In this study, it is possible that high and persistent levels of IL-1b resulted in prolonged overproduction of cortisol, which consequently saturated the intracellular glucocorticoid receptors, reducing receptor sensitivity (Pariante and Miller, 2001) . The latter mediates feedback inhibition of CRH (De Kloet et al., 1998) . Certain MYCO (e.g. T-2 toxin) when fed to the pigs at high levels increase plasma cortisol levels, which may be provoked by a severe reduction in feed intake (Rafai and Tuboly, 1982) . However, no effect of MYCO on plasma cortisol levels was observed in this study, which is in agreement with the findings of other investigators (Drochner et al., 2004; Leung et al., 2007) .
Intracellular concentrations of GSH represent the balance between rates of synthesis and loss from the cell. Several studies have demonstrated that GSH concentrations are diminished by disease, food deprivation (Hum et al., 1992) or protein and sulfur amino acid deficiency (Grimble et al., 1992; Jahoor et al., 1995) . Jahoor et al. (1995) reported that protein-deficient pigs are not able to maintain RBC GSH levels during inflammation, mainly because of the reduced synthesis rate of GSH. In our study, pigs on TURP, because of reduced feed intake, consumed 35% and 30% less protein than pigs on MYCO and LPS, respectively. This may partly explain the lower RBC GSH levels in TURP-treated pigs in our study. Alternatively, it can be speculated that lower levels of RBC GSH in TURP-treated pigs could be due to higher levels of oxidative stress in animals caused by severe local inflammation due to skin ulceration. This can lead to an increase in oxidation of GSH and its export from RBC (Jahoor et al., 1995; Breuille and Obled, 2000) .
In EXP II, ISS resulted in altered plasma levels of acute-phase proteins. Proinflammatory cytokines, IL-1, IL-6 and TNF-a, as well as corticosteroids play an essential role in initiating the synthesis of hepatic acute-phase proteins; therefore, the increased plasma haptoglobin and fibrinogen reflect ISS mediated by these molecules (Baumann et al., 1989; Jahoor et al., 1995) . Moreover, increased eye temperature, an indicator of internal BT, is modulated by the action of proinflammatory cytokines, in particular by IL-1b (Hughes et al., 1985; Dinarello, 2005) . Collectively, these results indicated that repeated injection of increasing amounts of LPS successfully stimulated the immune system in growing pigs
Conclusions and implications
Repeated injection of pigs with TURP induced severe responses, including skin ulcerations and substantial reductions in feed intake and BW gains. On the basis of plasma levels of IL-1b, feeding a mixture of naturally occurring MYCO did not provoke ISS. In contrast, repeated injection with increasing amounts of LPS induced a sustained chronic and relatively mild ISS. 
